These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
670 related items for PubMed ID: 19663129
21. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE. Drugs; 2009; 69(5):549-65. PubMed ID: 19368417 [Abstract] [Full Text] [Related]
22. Bronchodilation of formoterol administered with budesonide: device and formulation effects. Miller CJ, Senn S, Mezzanotte WS. Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985 [Abstract] [Full Text] [Related]
23. Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. Leidy NK, Gutierrez B, Lampl K, Uryniak T, O'Brien CD. J Asthma; 2009 Dec; 46(10):1006-12. PubMed ID: 19995138 [Abstract] [Full Text] [Related]
29. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E. Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085 [Abstract] [Full Text] [Related]
34. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O. Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303 [Abstract] [Full Text] [Related]
35. Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Buhl R, Creemers JP, Vondra V, Martelli NA, Naya IP, Ekström T. Respir Med; 2003 Apr; 97(4):323-30. PubMed ID: 12693793 [Abstract] [Full Text] [Related]
37. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. Morice AH, Peterson S, Beckman O, Kukova Z. Pulm Pharmacol Ther; 2008 Apr; 21(1):152-9. PubMed ID: 17376722 [Abstract] [Full Text] [Related]
38. Efficacy and safety of budesonide administered by pressurized metered-dose inhaler in children with asthma. Meltzer EO, Pearlman DS, Eckerwall G, Uryniak T, DePietro M, Lampl K. Ann Allergy Asthma Immunol; 2015 Dec; 115(6):516-22. PubMed ID: 26460293 [Abstract] [Full Text] [Related]
39. The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children. Berger WE, Leflein JG, Geller DE, Parasuraman B, Miller CJ, O'Brien CD, O'Dowd L. Allergy Asthma Proc; 2010 Dec; 31(1):26-39. PubMed ID: 20167143 [Abstract] [Full Text] [Related]
40. Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. Pohl WR, Vetter N, Zwick H, Hrubos W. Respir Med; 2006 Mar; 100(3):551-60. PubMed ID: 16005623 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]